Frequent co-localization of cox-2 and laminin-5 γ2 chain at the invasive front of early-stage lung adenocarcinomas

American Journal of Pathology

Volumn 160, Issue 3, 2002, Pages 1129-1141

  Niki, Toshiro ^a   Kohno, Takashi ^a   Iba, Sanae ^a   Moriya, Yasumitsu ^b   Takahashi, Yoko ^c   Saito, Miyuki ^c   Maeshima, Arafumi ^a   Yamada, Tesshi ^a   Matsuno, Yoshihiro ^a   Fukayama, Masashi ^c   Yokota, Jun ^a   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CELL PROTEIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KALININ; LAMININ 5 GAMMA2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INHIBITION; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; WESTERN BLOTTING;

EID: 0036121416     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64933-4     Document Type: Article

References (71)

1. Cyclooxygenase-2 inhibitors in tumorigenesis (part I)
2. Cyclooxygenase-2 inhibitors in tumorigenesis (part II)
3. Cyclooxygenase in biology and disease
4. The role of cyclooxygenases in inflammation, cancer, and development
5. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
6. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
7. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
8. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
9. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
10. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
11. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
12. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
13. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression
14. Cyciooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice
15. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
16. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
17. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
18. Expression of cyclooxygenase-2 in human gastric carcinoma
19. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
20. Cyclooxygenase-2 expression in human esophageal carcinoma
21. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
22. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
23. Expression of cyclooxygenase-2 in human lung carcinoma
24. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
25. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas
26. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines
27. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells
28. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases
29. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA
30. Superinduction of COX-2 mRNA by cycloheximide and inteleukin1 beta involves increased transcription and correlates with increased NF-kappaB and JNK activation
31. TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: Involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway
32. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway
33. Inhibition of cyclooxygenase-2 gene expression by p53
34. Increased expression of laminin-5 and its prognostic significance in small-sized lung adenocarcinoma: An immunohistochemical analysis of 102 cases
35. Laminin 5 deposition promotes keratinocyte motility
36. Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane
37. Marked stimulation of cell adhesion and motility by ladsin, a laminin-like scatter factor
38. Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin
39. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers
40. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas
41. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia
42. Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells
43. Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma
44. Laminin-5 as a marker of invasiveness in cervical lesions
45. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma
46. Clinicopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: Immunohistochemical analysis of 67 lesions
47. Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas
48. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma
49. Reduced mRNA expression of the DNA demethylase, MBD2, in human colorectal and stomach cancers
50. Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors
51. Epidermal growth factor receptor gene amplification is correlated with laminin-5 γ2 chain expression in oral squamous cell carcinoma cell lines
52. The ErbB signaling network: Receptor heterodimerization in development and cancer
53. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
54. Aberrant rel/nfkb genes and activity in human cancer
55. A labile repressor acts through the NFkappaB-like binding sites of the human urokinase gene
56. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumor-igenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8
57. NF-kappa B subunit-specific regulation of the interleukin-8 promoter
58. Inhibition of angiogenesis by anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
59. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases
60. Cyclooxygenase inhibitors retard murine mammary tumor progression by educing tumor cell migration, invasiveness and angiogenesis
61. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44
62. NSAIDS inhibit αV/β3 integrin-mediated and cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis
63. Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5
64. Processing of laminin-5 and its functional consequences: Role of plasmin and tissue-type plasminogen activator
65. Role of cell surface metalloprotease MT1-MMF in epithelial cell migration over laminin-5
66. Clinical implications of p53: Effect on prognosis, tumor progression and chemotherapy response
67. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression
68. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53
69. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product